Key result
Lower eGFR linked to increased arterial stiffness, ~12% mediated by fasting blood glucose.
Why the study?
It is uncertain whether the association between low eGFR and arterial stiffness in participants with kidney damage is direct or mediated by eGFR-associated increases in fasting blood glucose.
Does fasting blood glucose mediate the association between estimated glomerular filtration rate and arterial stiffness in a Japanese population with decreased kidney function?
Cross-Sectional (n=865)
Does fasting blood glucose mediate the association between estimated glomerular filtration rate and arterial stiffness in a Japanese population with decreased kidney function?
Effect estimate: β -25.68 (95% CI -46.42, -7.45)
Fasting blood glucose partially mediates the association between decreased kidney function and increased arterial stiffness, highlighting the potential importance of glycemic control in mitigating vascular risk in this population.
May implicate glycemic control in arterial stiffness with reduced eGFR; hypothesis-generating from cross-sectional data.
INTRODUCTION: Low estimated glomerular filtration rate (eGFR) is associated with an increased risk of arterial stiffness in participants with kidney damage. It is uncertain whether this association is due to eGFR itself or is mediated by the eGFR-associated increases in fasting blood glucose (FBG). METHOD: The cross-sectional study included 865 Japanese participants with decreased kidney function, whose eGFR was less than 90 mL/min/1.73 m2, and recruited individuals who received medical healthcare. The mediating variable was FBG, with eGFR as the independent variable and brachial-ankle pulse wave velocity (baPWV) as the dependent variable. A mediation analysis was used to evaluate the mediating effect of FBG on the association between eGFR and arterial stiffness. RESULTS: The mean age of the participants was 51.69 ± 9.25 years old, with 65.90% individuals being male. The mean values for FBG, eGFR, and baPWV were 5.46 ± 0.79 mmol/L, 68.83 ± 10.05 mL/min/1.73 m2, and 1,423.50 ± 247.78 cm/s, respectively. The mediation analysis revealed that eGFR had a significant direct effect on baPWV (β = -25.68 95% CI: -46.42, -7.45), and that FBG played a partial mediating role in the indirect effect of eGFR on baPWV (β = -3.54 95% CI: -11.88, -0.079). Mediation analysis showed that 12.10% of the effect of eGFR on risk of arterial stiffness was mediated through FBG. CONCLUSION: The study indicated that there is a mediating relationship between eGFR and FBG in people with decreased kidney function, which is associated with the risk of arterial stiffness. Therefore, the importance of FBG as a mediator should be acknowledged and taken into consideration.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2024) conducted a cross-sectional in Decreased kidney function (n=865). Estimated Glomerular Filtration Rate (eGFR) was evaluated on Brachial-ankle pulse wave velocity (baPWV) (β -25.68, 95% CI -46.42, -7.45). In adults with decreased kidney function, eGFR was significantly associated with arterial stiffness (β -25.68; 95% CI -46.42 to -7.45), with 12.1% of this effect mediated by fasting blood glucose.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: